Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.54 |
| ▸ | CNR2 | P34972 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL945677 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CNR1CNR2 | |
| SCHEMBL251553 | 0.95 | CNR1 (0.46) | ALDH1A1CNR1CNR2 | |
| SCHEMBL251555 | 0.95 | CNR1 (0.46) | ALDH1A1CNR1CNR2 | |
| SCHEMBL27320 | 0.91 | ALDH1A1 (0.43) | ALDH1A1CNR1CNR2 | |
| SCHEMBL1921025 | 0.87 | ALDH1A1 (0.56) | ALDH1A1CNR1CNR2 | |
| SCHEMBL5561906 | 0.86 | SPHK1 (0.43) | — | |
| SCHEMBL251629 | 0.86 | SPHK1 (0.43) | — | |
| SCHEMBL30290989 | 0.82 | ALDH1A1 (0.50) | ALDH1A1CNR1CNR2 | |
| SCHEMBL15018073 | 0.81 | ALDH1A1 (0.55) | ALDH1A1CNR1CNR2 | |
| SCHEMBL15018493 | 0.81 | ALDH1A1 (0.55) | ALDH1A1CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4264 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746913-A1 | LIPID NANOPARTICLES COMPRISING POLYMER-CONJUGATED LIPIDS AND USES THEREOF | Pfizer Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| WO-2026101351-A1 | METHOD FOR PREPARING LIPID NANOPARTICLES | 주식회사 테르나테라퓨틱스 | 2026-05-15 | — | — | WO | claimed |
| EP-4739652-A1 | LIPIDS AND COMPOSITIONS THEREOF | Kernal Biologics, Inc. (US) | 2026-05-13 | — | — | EP | claimed |
| WO-2026088119-A1 | LIPIDATED TLR7/8 MODULATORS AS ADJUVANTS AND USES THEREOF | PFIZER INC. (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260116845-A1 | LIPIDS AND COMPOSITIONS THEREOF | KERNAL BIOLOGICS INC (US) | 2026-04-30 | — | — | US | claimed |
| US-20260108473-A1 | BISPECIFIC STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | GENERATION BIO CO (US) | 2026-04-23 | — | — | US | claimed |
| EP-4709351-A1 | NANOPARTICLES FOR TRANSPORTING ACTIVE SUBSTANCES COMPRISING ANIONIC GROUPS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | Friedrich-Schiller-Universität Jena (DE) | 2026-03-18 | — | — | EP | claimed |
| US-20260062716-A1 | LIPID NANOPARTICLE (LNP) COMPOSITION OR FORMULATION FOR NUCLEIC ACID THERAPEUTICS | POPVAX PRIVATE LTD (IN) | 2026-03-05 | — | — | US | claimed |
| EP-4695401-A1 | SYNTHETIC CIRCUITS AND USES THEREOF | Strand Therapeutics Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4694913-A2 | LIPID NANOPARTICLES FOR GENE EDITING SYSTEMS | Orthobio Therapeutics, Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-1766035-A1 | LIPID ENCAPSULATED INTERFERING RNA | Protiva Biotherapeutics Inc. (CA) | 2007-03-28 | — | — | EP | claimed |
| WO-2006074546-A1 | LIPID ENCAPSULATED INTERFERING RNA | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2006-07-20 | — | — | WO | claimed |
| US-20060134189-A1 | siRNA silencing of apolipoprotein B | PROTIVA BIOTHERAPEUTICS, INC (CA) | 2006-06-22 | — | — | US | claimed |
| WO-2006053430-A1 | SIRNA SILENCING OF APOLIPOPROTEIN B | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2006-05-26 | — | — | WO | claimed |
| US-20060083780-A1 | Cationic lipids and methods of use | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2006-04-20 | — | — | US | claimed |
| US-20060051405-A1 | Compositions for the delivery of therapeutic agents and uses thereof | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2006-03-09 | — | — | US | claimed |
| US-20060008910-A1 | Lipid encapsulated interfering RNA | PROTIVA BIOTHERAPEUTIES, INC. (CA) | 2006-01-12 | — | — | US | claimed |
| WO-2006002538-A1 | IMMUNOSTIMULATORY SIRNA MOLECULES AND USES THEREFOR | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2006-01-12 | — | — | WO | claimed |
| WO-2005120152-A2 | CATIONIC LIPIDS AND METHODS OF USE | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2005-12-22 | — | — | WO | claimed |
| WO-2005121348-A1 | LIPID ENCAPSULATED INTERFERING RNA | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2005-12-22 | — | — | WO | claimed |